✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
Tirasemtiv is an investigational drug.
There have been 8 clinical trials for Tirasemtiv. The most recent clinical trial was a Phase 3 trial, which was initiated on October 17th 2016.
The most common disease conditions in clinical trials are Motor Neuron Disease, Amyotrophic Lateral Sclerosis, and Sclerosis. The leading clinical trial sponsors are Cytokinetics, National Institute of Neurological Disorders and Stroke (NINDS), and [disabled in preview].
There are fourteen US patents protecting this investigational drug and one hundred and twenty-three international patents.
Recent Clinical Trials for Tirasemtiv
|A Study for Patients Who Completed VITALITY-ALS (CY 4031)||Cytokinetics||Phase 3|
|Ventilatory Investigation of Tirasemtiv and Assessment of Longitudinal Indices After Treatment for a Year||Cytokinetics||Phase 3|
|Study of Safety, Tolerability & Efficacy of CK-2017357 in Amyotrophic Lateral Sclerosis (ALS)||Cytokinetics||Phase 2|
Top disease conditions for Tirasemtiv
Top clinical trial sponsors for Tirasemtiv
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Tirasemtiv||See Plans and Pricing||Increase of protein synthesis ameliorates synaptopathy-related neurological disorders||Academia Sinica (Taipei, TW)||See Plans and Pricing|
|Tirasemtiv||See Plans and Pricing||Controlled release dosage form||TRIASTEK, INC. (Nanjing, CN)||See Plans and Pricing|
|Tirasemtiv||See Plans and Pricing||Oral drug dosage forms having desired drug release profiles and uses thereof||Triastek, Inc. (Nanjing, CN)||See Plans and Pricing|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Tirasemtiv||Taiwan||TW201617070||2034-11-03||See Plans and Pricing|
|Tirasemtiv||Taiwan||TWI561235||2034-11-03||See Plans and Pricing|
|Tirasemtiv||Australia||AU2017261372||2036-05-05||See Plans and Pricing|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|